Simtra US LLC

Form 483 issued May 23, 2018 · Bloomington, Indiana

Inspection
May 16 – May 23, 2018
Observations
4
Pages
4
FEI number
1000115571

In short: On May 23, 2018, FDA issued a Form 483 with 4 observations to Simtra US LLC in Bloomington, Indiana (FEI 1000115571) after an inspection that ran May 16 – May 23, 2018. The investigators were Simone E. Pitts and Susan M. Jackson. Most observations concern production and laboratory controls; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Production and laboratory controls account for 3 of 4 observations.

Production2
Laboratory controls1
Quality system1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile do not include…

  2. 02

    Media fill batch manufacturing record 930381 executed to simulate the manufacturing process for Fluzone QIV- IM…

  3. 03

    There is no written testing program designed to assess the stability…

  4. 04

    There is a failure to thoroughly review the failure of a batch or any of its…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Simtra US LLC?

FDA listed 4 observations on this Form 483, mostly about production, laboratory controls and quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Simtra US LLC?

Simone E. Pitts and Susan M. Jackson are named on this Form 483, for the inspection of May 16 – May 23, 2018. Each investigator has a profile showing what they cite most.

When was Simtra US LLC inspected by FDA?

The inspection ran May 16 – May 23, 2018, and the Form 483 is dated May 23, 2018.

How do I get the full Form 483 for Simtra US LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free